Target intelligence / Profile preview

Zinc transporter ZIP1 (ZIP1)

Target
ZIP1
Molecular classification
Transporter, SLC (Solute carrier) family, Zinc transporter, Integral membrane protein
01

Overview

Zinc transporter ZIP1 (SLC39A1) is a member of the solute carrier family 39, responsible for zinc uptake into the cytoplasm across the cell membrane. ZIP1 has eight transmembrane domains and is widely expressed in mammalian tissues, with regulation of its plasma membrane localization in response to zinc status. It is especially critical in prostate cells, acting as the principal mediator of rapid zinc uptake. Downregulation of ZIP1 in prostate cancer leads to decreased zinc accumulation, impacting cellular metabolism and tumor suppression. As a transporter, ZIP1 is energy-independent and modulated by bicarbonate ions. Experimental and expression data support its role in various biological processes, including cell metabolism, cell cycle regulation, immune response, and apoptosis. ZIP1 is under investigation as a therapeutic target and biomarker, with zinc ionophores proposed in preclinical studies for prostate cancer management. Studies also highlight ZIP1's broader involvement in immune regulation and potential links to additional disease states such as neurodegeneration and immune-related disease.

Other names
SLC39A1Solute carrier family 39 member 1Zrt- and Irt-like protein 1IRT1ZIRTL
02

Mechanism of action

Zinc ionophores (such as clioquinol) increase zinc influx by facilitating transport through ZIP1, potentially restoring tumor suppressor function via zinc accumulation in prostate cells.

03

Biological functions

Regulation of cellular zinc uptake and homeostasisResponse to hormonal and zinc status signalsSupport of cell metabolism and cell cycle regulationTumor suppressor activity (notably in prostate)Modulation of immune response
04

Disease associations

Cancer (especially prostate cancer)Tumor suppressionPotential roles in neurodegenerationImmune regulation (immune infiltration correlations in cancer, experimental data in plant immunity)
05

Safety considerations

Cytotoxicity from excessive zinc accumulation
06

Interacting drugs

Clioquinol (zinc ionophore, used in research for prostate cancer therapy)
07

Biomarkers

ZIP1 expression levels as a prostate cancer biomarker (lower levels observed in tumors)

Beyond the preview

Go deeper on Zinc transporter ZIP1 (ZIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter ZIP1 (ZIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call